Interdisciplinary Intervention for Hospitalized Patients with Substance Use Disorders
This study is testing a new program called IntACT (Interdisciplinary Addiction Care Transition) to help hospitalized patients with substance use disorders (SUDs) as they move from hospital care back to their communities. IntACT provides extra support like discharge planning, follow-up outreach, and peer support. You might receive IntACT or usual care, which is the standard support currently available. The study aims to see if IntACT is practical to implement and how well it helps patients connect to ongoing care and stay in treatment. To join, you must be 18 or older, hospitalized at the University of Utah Medical Center, and have a documented SUD diagnosis. The study plans to enroll 75 participants.
- Study design
- This is a pilot randomized controlled trial, meaning participants are randomly assigned to one of two groups. It is unblinded, so participants and researchers will know which treatment is being received.
- What's involved
- Participants will receive either the IntACT intervention or usual care for up to 4 months. The IntACT team will meet with participants in the hospital and provide ongoing support and care coordination after discharge.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' connection to care will be checked at 14 days, and their retention in treatment will be measured at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Feasibility of an Interdisciplinary Intervention to Improve Care Transitions for Hospitalized Patients With Substance Use Disorders
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael Incze, MD · PRINCIPAL_INVESTIGATOR · University of Utah
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Care Linkage14 Days
percentage of patients who attend any follow up visit within 14 days of hospital discharge. Assessed using administrative records and patient self-report.
- Retention in Treatment6 Months
Percentage of patients who have attended a medical or substance use treatment appointment within the past 30 days. Assessed at 2 months, 4 months, and 6 months after randomization. Assessed using clinic/administrative records and patient-self-report.
- Intervention FeasibilityCompleted once within 2 weeks of exposure to the intervention
Implementation-related outcomes will be collected from N=20 clinicians who are exposed to the IntACT intervention and IntACT team members, respectively. Implementation outcomes include Feasibility, assessed via the 4-item Feasibility of Intervention measure (range 0-12, higher is more feasible)
- Intervention AcceptabilityCompleted once within 2 weeks of exposure to the intervention
Implementation-related outcomes will be collected from N=20 clinicians who are exposed to the IntACT intervention and IntACT team members, respectively. Implementation outcomes include Acceptability, assessed via the 4-item Acceptability of Intervention measure (range 0-12, higher is more acceptible)
- Intervention AppropriatenessCompleted once within 2 weeks of exposure to the intervention
Implementation-related outcomes will be collected from N=20 clinicians who are exposed to the IntACT intervention and IntACT team members, respectively. Implementation outcomes include Appropriateness, assessed via the 4-item Intervention Appropriateness Measure (range 0-12, higher is more appropriate)